Table 1.
Anthropometric and biochemical profile of patients with SBMA and control subjects.
| SBMA (n. 47) |
Control (n. 124) |
p value | |
|---|---|---|---|
| Age (years) | 57.7 ± 7.0 | 55.3 ± 8.4 | n.s. |
| BMI (kg/m2) | 25.5 ± 3.7 | 24.8 ± 3.4 | n.s. |
| Waist circumference (cm) | 101 ± 7.5 | 98 ± 8.1 | < 0.05 |
| SBP (mmHg) | 138 ± 18 | 129 ± 13 | < 0.001 |
| DBP (mmHg) | 90 ± 10 | 86 ± 9 | < 0.01 |
| Fasting glucose (mmol/l) | 115 ± 34 | 108 ± 21 | n.s. |
| Glycate haemoglobin (mmol/mol) | 41 ± 13 | 37 ± 11 | < 0.05 |
| IRI (μU/ml) | 15.0 ± 10.7 | 8.8 ± 7.2 | < 0.001 |
| HOMA-IR | 4.1 ± 2.5 | 2.1 ± 2.0 | < 0.001 |
| Total cholesterol (mmol/l) | 5.36 ± 0.84 | 5.21 ± 0.76 | n.s |
| HDL-cholesterol (mmol/l) | 1.38 ± 0.42 | 1.43 ± 0.39 | n.s. |
| Triglycerides (mmol/L) | 1.98 ± 1.26 | 1.72 ± 1.11 | n.s. |
| AST (U/L) | 47 ± 21 | 25 ± 11 | < 0.001 |
| ALT (U/L) | 57 ± 27 | 27 ± 15 | < 0.001 |
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; IRI: immuno-reactive insulin; HOMA-IR: insulin resistance homeostatic model assessment; HDL: high-density lipoprotein; AST: aspartate transaminase; ALT: alanine transaminase.